Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Allergy, Drug

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Allergy, Drug in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hartman, RP; Hunt, CH; Kallmes, DF; Kolbe, AB; Maddox, DE; McDonald, JS; McDonald, RJ; Schmitz, JJ1
Beaudouin, E; Blanloeil, Y; Guilloux, L; Kanny, G; Moneret-Vautrin, DA; Renaudin, JM1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Allergy, Drug

ArticleYear
Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
    Radiology, 2019, Volume: 292, Issue:3

    Topics: Acute Disease; Adult; Aged; Contrast Media; Drug Hypersensitivity; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors

2019
Anaphylactic shock induced by gadoterate meglumine (DOTAREM).
    European annals of allergy and clinical immunology, 2003, Volume: 35, Issue:10

    Topics: Adult; Anaphylaxis; Contrast Media; Cross Reactions; Drug Hypersensitivity; Female; Gadolinium DTPA; Heterocyclic Compounds; Histamine Release; Humans; Intradermal Tests; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds

2003